Literature DB >> 30082545

Outcomes of surgically treated oral cancer patients at a tertiary cancer center in India.

Deepa Nair1, Hitesh Singhvi1, Manish Mair1, Burhanuddin Qayyumi1, Anuja Deshmukh1, Gouri Pantvaidya1, Sudhir Nair1, Pankaj Chaturvedi1, Sarbani Ghosh Laskar2, Kumar Prabhash3, Anil DCruz4.   

Abstract

BACKGROUND: Oral cancers are one of the most common cancers in India. Surgery is the main modality of treatment for oral cancer patients. It is important to understand the postoperative morbidity and mortality as it influences patient outcomes. AIM: The aim of this study was to determine oral cancer patients' characteristics, treatment details, 30-day morbidity and mortality, and survival outcomes. SETTINGS AND
DESIGN: This was a retrospective analysis of prospectively collected data in a tertiary cancer center.
MATERIALS AND METHODS: This study included 850 surgically treated oral cancer cases between January and December 2012. STATISTICAL ANALYSIS: We performed univariate survival analysis by log-rank test, and all significant (P < 0.05) variables underwent multivariate analysis using Cox regression.
RESULTS: The median age was 52 years and the male-to-female ratio was 3.4:1. Nearly one-third of the patients received some form of prior treatment. Buccal mucosa (BM) was the most common subsite (64.94%). BM cancers (81.1%) were more likely to present in advanced stage compared to tongue cancers (52%) (P = 0.000). The incidence of postoperative morbidity and mortality was 36.4% and 0.9%, respectively. Complications were higher in cT3-4 (P = 0.000), cN positive (P = 0.000), and those requiring microvascular reconstruction (P = 0.004). The 5-year overall survival of the entire study group was 70.4%. The survival of early and locally advanced stages was 75.1% and 68.4%, respectively. The factors influencing survival were age (>50 years), advanced cT stage, nodal metastasis, overall stage, and presence of orocutaneous fistula.
CONCLUSION: The morbidity, mortality, and long-term outcomes of surgically treated oral cancer patients at our center are comparable to those treated in the developed world. Aggressive management of postoperative complications is crucial for early recovery and timely initiation of adjuvant treatment.

Entities:  

Keywords:  Complications; oral concers; outcomes; surgery

Mesh:

Year:  2017        PMID: 30082545     DOI: 10.4103/ijc.IJC_445_17

Source DB:  PubMed          Journal:  Indian J Cancer        ISSN: 0019-509X            Impact factor:   1.224


  6 in total

1.  Making the Best of Limited Resources: Improving Outcomes in Head and Neck Cancer.

Authors:  Johannes J Fagan; Vanita Noronha; Evan Michael Graboyes
Journal:  Am Soc Clin Oncol Educ Book       Date:  2021-03

Review 2.  Molecular Insights into Oral Malignancy.

Authors:  Anuja Deshmukh; Karthik Nagaraja Rao; Ripu Daman Arora; Nitin M Nagarkar; Ambesh Singh; Om Shree Shetty
Journal:  Indian J Surg Oncol       Date:  2021-09-11

3.  Distant metastasis in oral squamous cell carcinoma: Does the neutrophil-to-lymphocyte ratio act as a surrogate of the host immune status?

Authors:  Daniella Karassawa Zanoni; Cristina Valero; Marlena R McGill; Pablo H Montero; Jatin P Shah; Richard J Wong; Ian Ganly; Snehal G Patel
Journal:  Oral Oncol       Date:  2021-12-01       Impact factor: 5.972

4.  Should we wait or not? The preferable option for patients with stage IV oral cancer in COVID-19 pandemic.

Authors:  Atanu Bhattacharjee; Vijay M Patil; Rajesh Dikshit; Kumar Prabhash; Arjun Singh; Pankaj Chaturvedi
Journal:  Head Neck       Date:  2020-04-28       Impact factor: 3.147

5.  ET-1 Promotes Epithelial-Mesenchymal Transition in Oral Squamous Cell Carcinoma Cells via the microRNA-489-3p /TWIST Axis.

Authors:  Huey-En Tzeng; Chih-Hsin Tang; Chun-Hao Tsai; Chih-Hui Chiu; Min-Huan Wu; Yun Yen
Journal:  Onco Targets Ther       Date:  2021-10-06       Impact factor: 4.147

6.  A prospective study to determine the cost of illness for oral cancer in India.

Authors:  Arjun Gurmeet Singh; Devendra Chaukar; Sudeep Gupta; C S Pramesh; Richard Sullivan; Pankaj Chaturvedi; Rajendra Badwe
Journal:  Ecancermedicalscience       Date:  2021-06-17
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.